July 09, 2014
Ultragenyx Announces Pricing of Public Offering of Common Stock
Media
July 07, 2014
The Orthopaedic Revolution
July 07, 2014
Nordic Nanovector Listing on NOTC
July 03, 2014
Accelerated FDA approval of Topotarget’s Beleodaq™
July 02, 2014
New clinical review gives practicing physicians’ recommendations for how to use Arocrine’s FeNO-Test in routine clinical practice.
July 01, 2014
Ultragenyx Announces Initiation of a Phase 2 Study of KRN23 for Pediatric X-Linked Hypophosphatemia in the US and EU
June 30, 2014
Orexo Added to Russell Global Index
May 24, 2014
HealthCap Presentation Farmasidagene 2014 Oslo
May 14, 2014
Nordic Nanovector Q1 2014 results
May 05, 2014
Q1 2014 General Market Overview